Clinical Trial Update: The Role of miRNA in Group 3 Pulmonary Hypertension

View source ↗

Summary

This clinical trial update examines the potential role of microRNA in Group 3 pulmonary hypertension. The study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Pulmonary Hypertension | Status: ACTIVE_NOT_RECRUITING